Bioventus, Inc. (BVS)
13.33
-1.54
(-10.36%)
USD |
NASDAQ |
Oct 30, 16:00
13.28
-0.05
(-0.38%)
After-Hours: 20:00
Bioventus Enterprise Value : 1.298B for Oct. 29, 2026
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| October 29, 2026 | 1.298B |
| October 28, 2026 | 1.283B |
| October 27, 2026 | 1.267B |
| October 26, 2026 | 1.287B |
| October 23, 2026 | 1.304B |
| October 22, 2026 | 1.309B |
| October 21, 2026 | 1.255B |
| October 20, 2026 | 1.235B |
| October 19, 2026 | 1.204B |
| October 16, 2026 | 1.191B |
| October 15, 2026 | 1.225B |
| October 14, 2026 | 1.204B |
| October 13, 2026 | 1.208B |
| October 12, 2026 | 1.206B |
| October 09, 2026 | 1.175B |
| October 08, 2026 | 1.149B |
| October 07, 2026 | 1.154B |
| October 06, 2026 | 1.177B |
| October 05, 2026 | 1.206B |
| October 02, 2026 | 1.179B |
| October 01, 2026 | 1.201B |
| September 30, 2026 | 1.213B |
| September 29, 2026 | 1.238B |
| September 28, 2026 | 1.240B |
| September 25, 2026 | 1.225B |
| Date | Value |
|---|---|
| September 24, 2026 | 1.206B |
| September 23, 2026 | 1.212B |
| September 22, 2026 | 1.214B |
| September 21, 2026 | 1.191B |
| September 18, 2026 | 1.164B |
| September 17, 2026 | 1.145B |
| September 16, 2026 | 1.184B |
| September 15, 2026 | 1.170B |
| September 14, 2026 | 1.181B |
| September 11, 2026 | 1.169B |
| September 10, 2026 | 1.174B |
| September 09, 2026 | 1.213B |
| September 08, 2026 | 1.227B |
| September 04, 2026 | 1.243B |
| September 03, 2026 | 1.263B |
| September 02, 2026 | 1.264B |
| September 01, 2026 | 1.216B |
| August 31, 2026 | 1.214B |
| August 28, 2026 | 1.227B |
| August 27, 2026 | 1.224B |
| August 26, 2026 | 1.236B |
| August 25, 2026 | 1.244B |
| August 24, 2026 | 1.240B |
| August 21, 2026 | 1.264B |
| August 20, 2026 | 1.261B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Accuray, Inc. | 163.20M |
| Micron Solutions, Inc. | -- |
| Orthofix Medical, Inc. | 574.57M |
| ResMed, Inc. | 35.82B |
| Rockwell Medical, Inc. | 18.17M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | 36.20M |
| Revenue (Quarterly) | 153.21M |
| Total Expenses (Quarterly) | 119.77M |
| EPS Diluted (Quarterly) | 0.4721 |
| Gross Profit Margin (Quarterly) | 68.29% |
| Profit Margin (Quarterly) | 23.63% |
| Earnings Yield | 5.82% |
| Operating Earnings Yield | 6.61% |
| Normalized Earnings Yield | 6.075 |